Saturday, November 16, 2024
- Advertisement -spot_img

TAG

Cushing's disease

Crinetics Pharmaceuticals Inc (CRNX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid …

Cash and Investments: Approximately $863 million as of the end of Q2 2024.Research and Development Expenses: $58.3 million for Q2 2024, up from $40.6...

Latest news

- Advertisement -spot_img